Home Healthcare Biotechnology DNA Synthesis Market

DNA Synthesis Market Size, Share & Trends Analysis Report By Product & Services (Instruments, Reagents & Consumables, Service, Oligonucleotide Synthesis, Gene Synthesis), By Application (Research & Development, Diagnostics, Therapeutics, RNAi Therapies, Antisense Oligonucleotide-based Therapies, Others), By End Use (Pharmaceutical & Biopharmaceutical Companies, Diagnostic Companies, Academic & Research Institutes, CROs & CDMOs) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: June 23, 2026 | Author: Dhanashri B | Format:
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. DNA Synthesis Market, By Product & Services 2022-2034 (USD MILLION/ Units)
    1. Instruments
    2. Reagents & Consumables
    3. Service
    4. Oligonucleotide Synthesis
    5. Gene Synthesis
  2. DNA Synthesis Market, By Application  2022-2034 (USD MILLION/ Units)
    1. Research & Development
    2. Diagnostics
    3. Therapeutics
    4. RNAi Therapies
    5. Antisense Oligonucleotide-based Therapies
    6. Others
  3. DNA Synthesis Market, By End Use 2022-2034 (USD MILLION/ Units)
    1. Pharmaceutical & Biopharmaceutical Companies
    2. Diagnostic Companies
    3. Academic & Research Institutes
    4. CROs & CDMOs
  4. Regional DNA Synthesis Market
    1. North America
      1. North America DNA Synthesis Market By Product & Services 2022-2034 (USD MILLION/ Units)
        1. Instruments
        2. Reagents & Consumables
        3. Service
        4. Oligonucleotide Synthesis
        5. Gene Synthesis
      2. North America DNA Synthesis Market By Application  2022-2034 (USD MILLION/ Units)
        1. Research & Development
        2. Diagnostics
        3. Therapeutics
        4. RNAi Therapies
        5. Antisense Oligonucleotide-based Therapies
        6. Others
      3. North America DNA Synthesis Market By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical & Biopharmaceutical Companies
        2. Diagnostic Companies
        3. Academic & Research Institutes
        4. CROs & CDMOs
      4. U.S.
        1. Instruments
        2. Reagents & Consumables
        3. Service
        4. Oligonucleotide Synthesis
        5. Gene Synthesis
        6. Research & Development
        7. Diagnostics
        8. Therapeutics
        9. RNAi Therapies
        10. Antisense Oligonucleotide-based Therapies
        11. Others
        12. Pharmaceutical & Biopharmaceutical Companies
        13. Diagnostic Companies
        14. Academic & Research Institutes
        15. CROs & CDMOs
      5. Canada
        1. Instruments
        2. Reagents & Consumables
        3. Service
        4. Oligonucleotide Synthesis
        5. Gene Synthesis
        6. Research & Development
        7. Diagnostics
        8. Therapeutics
        9. RNAi Therapies
        10. Antisense Oligonucleotide-based Therapies
        11. Others
        12. Pharmaceutical & Biopharmaceutical Companies
        13. Diagnostic Companies
        14. Academic & Research Institutes
        15. CROs & CDMOs
    2. Europe
      1. Europe DNA Synthesis Market By Product & Services 2022-2034 (USD MILLION/ Units)
        1. Instruments
        2. Reagents & Consumables
        3. Service
        4. Oligonucleotide Synthesis
        5. Gene Synthesis
      2. Europe DNA Synthesis Market By Application  2022-2034 (USD MILLION/ Units)
        1. Research & Development
        2. Diagnostics
        3. Therapeutics
        4. RNAi Therapies
        5. Antisense Oligonucleotide-based Therapies
        6. Others
      3. Europe DNA Synthesis Market By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical & Biopharmaceutical Companies
        2. Diagnostic Companies
        3. Academic & Research Institutes
        4. CROs & CDMOs
      4. U.K.
        1. Instruments
        2. Reagents & Consumables
        3. Service
        4. Oligonucleotide Synthesis
        5. Gene Synthesis
        6. Research & Development
        7. Diagnostics
        8. Therapeutics
        9. RNAi Therapies
        10. Antisense Oligonucleotide-based Therapies
        11. Others
        12. Pharmaceutical & Biopharmaceutical Companies
        13. Diagnostic Companies
        14. Academic & Research Institutes
        15. CROs & CDMOs
      5. Germany
        1. Instruments
        2. Reagents & Consumables
        3. Service
        4. Oligonucleotide Synthesis
        5. Gene Synthesis
        6. Research & Development
        7. Diagnostics
        8. Therapeutics
        9. RNAi Therapies
        10. Antisense Oligonucleotide-based Therapies
        11. Others
        12. Pharmaceutical & Biopharmaceutical Companies
        13. Diagnostic Companies
        14. Academic & Research Institutes
        15. CROs & CDMOs
      6. France
        1. Instruments
        2. Reagents & Consumables
        3. Service
        4. Oligonucleotide Synthesis
        5. Gene Synthesis
        6. Research & Development
        7. Diagnostics
        8. Therapeutics
        9. RNAi Therapies
        10. Antisense Oligonucleotide-based Therapies
        11. Others
        12. Pharmaceutical & Biopharmaceutical Companies
        13. Diagnostic Companies
        14. Academic & Research Institutes
        15. CROs & CDMOs
      7. Spain
        1. Instruments
        2. Reagents & Consumables
        3. Service
        4. Oligonucleotide Synthesis
        5. Gene Synthesis
        6. Research & Development
        7. Diagnostics
        8. Therapeutics
        9. RNAi Therapies
        10. Antisense Oligonucleotide-based Therapies
        11. Others
        12. Pharmaceutical & Biopharmaceutical Companies
        13. Diagnostic Companies
        14. Academic & Research Institutes
        15. CROs & CDMOs
      8. Italy
        1. Instruments
        2. Reagents & Consumables
        3. Service
        4. Oligonucleotide Synthesis
        5. Gene Synthesis
        6. Research & Development
        7. Diagnostics
        8. Therapeutics
        9. RNAi Therapies
        10. Antisense Oligonucleotide-based Therapies
        11. Others
        12. Pharmaceutical & Biopharmaceutical Companies
        13. Diagnostic Companies
        14. Academic & Research Institutes
        15. CROs & CDMOs
      9. Russia
        1. Instruments
        2. Reagents & Consumables
        3. Service
        4. Oligonucleotide Synthesis
        5. Gene Synthesis
        6. Research & Development
        7. Diagnostics
        8. Therapeutics
        9. RNAi Therapies
        10. Antisense Oligonucleotide-based Therapies
        11. Others
        12. Pharmaceutical & Biopharmaceutical Companies
        13. Diagnostic Companies
        14. Academic & Research Institutes
        15. CROs & CDMOs
      10. Nordic
        1. Instruments
        2. Reagents & Consumables
        3. Service
        4. Oligonucleotide Synthesis
        5. Gene Synthesis
        6. Research & Development
        7. Diagnostics
        8. Therapeutics
        9. RNAi Therapies
        10. Antisense Oligonucleotide-based Therapies
        11. Others
        12. Pharmaceutical & Biopharmaceutical Companies
        13. Diagnostic Companies
        14. Academic & Research Institutes
        15. CROs & CDMOs
      11. Benelux
        1. Instruments
        2. Reagents & Consumables
        3. Service
        4. Oligonucleotide Synthesis
        5. Gene Synthesis
        6. Research & Development
        7. Diagnostics
        8. Therapeutics
        9. RNAi Therapies
        10. Antisense Oligonucleotide-based Therapies
        11. Others
        12. Pharmaceutical & Biopharmaceutical Companies
        13. Diagnostic Companies
        14. Academic & Research Institutes
        15. CROs & CDMOs
      12. Rest of Europe
        1. Instruments
        2. Reagents & Consumables
        3. Service
        4. Oligonucleotide Synthesis
        5. Gene Synthesis
        6. Research & Development
        7. Diagnostics
        8. Therapeutics
        9. RNAi Therapies
        10. Antisense Oligonucleotide-based Therapies
        11. Others
        12. Pharmaceutical & Biopharmaceutical Companies
        13. Diagnostic Companies
        14. Academic & Research Institutes
        15. CROs & CDMOs
    3. APAC
      1. APAC DNA Synthesis Market By Product & Services 2022-2034 (USD MILLION/ Units)
        1. Instruments
        2. Reagents & Consumables
        3. Service
        4. Oligonucleotide Synthesis
        5. Gene Synthesis
      2. APAC DNA Synthesis Market By Application  2022-2034 (USD MILLION/ Units)
        1. Research & Development
        2. Diagnostics
        3. Therapeutics
        4. RNAi Therapies
        5. Antisense Oligonucleotide-based Therapies
        6. Others
      3. APAC DNA Synthesis Market By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical & Biopharmaceutical Companies
        2. Diagnostic Companies
        3. Academic & Research Institutes
        4. CROs & CDMOs
      4. China
        1. Instruments
        2. Reagents & Consumables
        3. Service
        4. Oligonucleotide Synthesis
        5. Gene Synthesis
        6. Research & Development
        7. Diagnostics
        8. Therapeutics
        9. RNAi Therapies
        10. Antisense Oligonucleotide-based Therapies
        11. Others
        12. Pharmaceutical & Biopharmaceutical Companies
        13. Diagnostic Companies
        14. Academic & Research Institutes
        15. CROs & CDMOs
      5. Korea
        1. Instruments
        2. Reagents & Consumables
        3. Service
        4. Oligonucleotide Synthesis
        5. Gene Synthesis
        6. Research & Development
        7. Diagnostics
        8. Therapeutics
        9. RNAi Therapies
        10. Antisense Oligonucleotide-based Therapies
        11. Others
        12. Pharmaceutical & Biopharmaceutical Companies
        13. Diagnostic Companies
        14. Academic & Research Institutes
        15. CROs & CDMOs
      6. Japan
        1. Instruments
        2. Reagents & Consumables
        3. Service
        4. Oligonucleotide Synthesis
        5. Gene Synthesis
        6. Research & Development
        7. Diagnostics
        8. Therapeutics
        9. RNAi Therapies
        10. Antisense Oligonucleotide-based Therapies
        11. Others
        12. Pharmaceutical & Biopharmaceutical Companies
        13. Diagnostic Companies
        14. Academic & Research Institutes
        15. CROs & CDMOs
      7. India
        1. Instruments
        2. Reagents & Consumables
        3. Service
        4. Oligonucleotide Synthesis
        5. Gene Synthesis
        6. Research & Development
        7. Diagnostics
        8. Therapeutics
        9. RNAi Therapies
        10. Antisense Oligonucleotide-based Therapies
        11. Others
        12. Pharmaceutical & Biopharmaceutical Companies
        13. Diagnostic Companies
        14. Academic & Research Institutes
        15. CROs & CDMOs
      8. Australia
        1. Instruments
        2. Reagents & Consumables
        3. Service
        4. Oligonucleotide Synthesis
        5. Gene Synthesis
        6. Research & Development
        7. Diagnostics
        8. Therapeutics
        9. RNAi Therapies
        10. Antisense Oligonucleotide-based Therapies
        11. Others
        12. Pharmaceutical & Biopharmaceutical Companies
        13. Diagnostic Companies
        14. Academic & Research Institutes
        15. CROs & CDMOs
      9. Taiwan
        1. Instruments
        2. Reagents & Consumables
        3. Service
        4. Oligonucleotide Synthesis
        5. Gene Synthesis
        6. Research & Development
        7. Diagnostics
        8. Therapeutics
        9. RNAi Therapies
        10. Antisense Oligonucleotide-based Therapies
        11. Others
        12. Pharmaceutical & Biopharmaceutical Companies
        13. Diagnostic Companies
        14. Academic & Research Institutes
        15. CROs & CDMOs
      10. South East Asia
        1. Instruments
        2. Reagents & Consumables
        3. Service
        4. Oligonucleotide Synthesis
        5. Gene Synthesis
        6. Research & Development
        7. Diagnostics
        8. Therapeutics
        9. RNAi Therapies
        10. Antisense Oligonucleotide-based Therapies
        11. Others
        12. Pharmaceutical & Biopharmaceutical Companies
        13. Diagnostic Companies
        14. Academic & Research Institutes
        15. CROs & CDMOs
      11. Rest of Asia-Pacific
        1. Instruments
        2. Reagents & Consumables
        3. Service
        4. Oligonucleotide Synthesis
        5. Gene Synthesis
        6. Research & Development
        7. Diagnostics
        8. Therapeutics
        9. RNAi Therapies
        10. Antisense Oligonucleotide-based Therapies
        11. Others
        12. Pharmaceutical & Biopharmaceutical Companies
        13. Diagnostic Companies
        14. Academic & Research Institutes
        15. CROs & CDMOs
    4. Middle East and Africa
      1. Middle East and Africa DNA Synthesis Market By Product & Services 2022-2034 (USD MILLION/ Units)
        1. Instruments
        2. Reagents & Consumables
        3. Service
        4. Oligonucleotide Synthesis
        5. Gene Synthesis
      2. Middle East and Africa DNA Synthesis Market By Application  2022-2034 (USD MILLION/ Units)
        1. Research & Development
        2. Diagnostics
        3. Therapeutics
        4. RNAi Therapies
        5. Antisense Oligonucleotide-based Therapies
        6. Others
      3. Middle East and Africa DNA Synthesis Market By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical & Biopharmaceutical Companies
        2. Diagnostic Companies
        3. Academic & Research Institutes
        4. CROs & CDMOs
      4. UAE
        1. Instruments
        2. Reagents & Consumables
        3. Service
        4. Oligonucleotide Synthesis
        5. Gene Synthesis
        6. Research & Development
        7. Diagnostics
        8. Therapeutics
        9. RNAi Therapies
        10. Antisense Oligonucleotide-based Therapies
        11. Others
        12. Pharmaceutical & Biopharmaceutical Companies
        13. Diagnostic Companies
        14. Academic & Research Institutes
        15. CROs & CDMOs
      5. Turkey
        1. Instruments
        2. Reagents & Consumables
        3. Service
        4. Oligonucleotide Synthesis
        5. Gene Synthesis
        6. Research & Development
        7. Diagnostics
        8. Therapeutics
        9. RNAi Therapies
        10. Antisense Oligonucleotide-based Therapies
        11. Others
        12. Pharmaceutical & Biopharmaceutical Companies
        13. Diagnostic Companies
        14. Academic & Research Institutes
        15. CROs & CDMOs
      6. Saudi Arabia
        1. Instruments
        2. Reagents & Consumables
        3. Service
        4. Oligonucleotide Synthesis
        5. Gene Synthesis
        6. Research & Development
        7. Diagnostics
        8. Therapeutics
        9. RNAi Therapies
        10. Antisense Oligonucleotide-based Therapies
        11. Others
        12. Pharmaceutical & Biopharmaceutical Companies
        13. Diagnostic Companies
        14. Academic & Research Institutes
        15. CROs & CDMOs
      7. South Africa
        1. Instruments
        2. Reagents & Consumables
        3. Service
        4. Oligonucleotide Synthesis
        5. Gene Synthesis
        6. Research & Development
        7. Diagnostics
        8. Therapeutics
        9. RNAi Therapies
        10. Antisense Oligonucleotide-based Therapies
        11. Others
        12. Pharmaceutical & Biopharmaceutical Companies
        13. Diagnostic Companies
        14. Academic & Research Institutes
        15. CROs & CDMOs
      8. Egypt
        1. Instruments
        2. Reagents & Consumables
        3. Service
        4. Oligonucleotide Synthesis
        5. Gene Synthesis
        6. Research & Development
        7. Diagnostics
        8. Therapeutics
        9. RNAi Therapies
        10. Antisense Oligonucleotide-based Therapies
        11. Others
        12. Pharmaceutical & Biopharmaceutical Companies
        13. Diagnostic Companies
        14. Academic & Research Institutes
        15. CROs & CDMOs
      9. Nigeria
        1. Instruments
        2. Reagents & Consumables
        3. Service
        4. Oligonucleotide Synthesis
        5. Gene Synthesis
        6. Research & Development
        7. Diagnostics
        8. Therapeutics
        9. RNAi Therapies
        10. Antisense Oligonucleotide-based Therapies
        11. Others
        12. Pharmaceutical & Biopharmaceutical Companies
        13. Diagnostic Companies
        14. Academic & Research Institutes
        15. CROs & CDMOs
      10. Rest of MEA
        1. Instruments
        2. Reagents & Consumables
        3. Service
        4. Oligonucleotide Synthesis
        5. Gene Synthesis
        6. Research & Development
        7. Diagnostics
        8. Therapeutics
        9. RNAi Therapies
        10. Antisense Oligonucleotide-based Therapies
        11. Others
        12. Pharmaceutical & Biopharmaceutical Companies
        13. Diagnostic Companies
        14. Academic & Research Institutes
        15. CROs & CDMOs
    5. LATAM
      1. LATAM DNA Synthesis Market By Product & Services 2022-2034 (USD MILLION/ Units)
        1. Instruments
        2. Reagents & Consumables
        3. Service
        4. Oligonucleotide Synthesis
        5. Gene Synthesis
      2. LATAM DNA Synthesis Market By Application  2022-2034 (USD MILLION/ Units)
        1. Research & Development
        2. Diagnostics
        3. Therapeutics
        4. RNAi Therapies
        5. Antisense Oligonucleotide-based Therapies
        6. Others
      3. LATAM DNA Synthesis Market By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical & Biopharmaceutical Companies
        2. Diagnostic Companies
        3. Academic & Research Institutes
        4. CROs & CDMOs
      4. Brazil
        1. Instruments
        2. Reagents & Consumables
        3. Service
        4. Oligonucleotide Synthesis
        5. Gene Synthesis
        6. Research & Development
        7. Diagnostics
        8. Therapeutics
        9. RNAi Therapies
        10. Antisense Oligonucleotide-based Therapies
        11. Others
        12. Pharmaceutical & Biopharmaceutical Companies
        13. Diagnostic Companies
        14. Academic & Research Institutes
        15. CROs & CDMOs
      5. Mexico
        1. Instruments
        2. Reagents & Consumables
        3. Service
        4. Oligonucleotide Synthesis
        5. Gene Synthesis
        6. Research & Development
        7. Diagnostics
        8. Therapeutics
        9. RNAi Therapies
        10. Antisense Oligonucleotide-based Therapies
        11. Others
        12. Pharmaceutical & Biopharmaceutical Companies
        13. Diagnostic Companies
        14. Academic & Research Institutes
        15. CROs & CDMOs
      6. Argentina
        1. Instruments
        2. Reagents & Consumables
        3. Service
        4. Oligonucleotide Synthesis
        5. Gene Synthesis
        6. Research & Development
        7. Diagnostics
        8. Therapeutics
        9. RNAi Therapies
        10. Antisense Oligonucleotide-based Therapies
        11. Others
        12. Pharmaceutical & Biopharmaceutical Companies
        13. Diagnostic Companies
        14. Academic & Research Institutes
        15. CROs & CDMOs
      7. Chile
        1. Instruments
        2. Reagents & Consumables
        3. Service
        4. Oligonucleotide Synthesis
        5. Gene Synthesis
        6. Research & Development
        7. Diagnostics
        8. Therapeutics
        9. RNAi Therapies
        10. Antisense Oligonucleotide-based Therapies
        11. Others
        12. Pharmaceutical & Biopharmaceutical Companies
        13. Diagnostic Companies
        14. Academic & Research Institutes
        15. CROs & CDMOs
      8. Colombia
        1. Instruments
        2. Reagents & Consumables
        3. Service
        4. Oligonucleotide Synthesis
        5. Gene Synthesis
        6. Research & Development
        7. Diagnostics
        8. Therapeutics
        9. RNAi Therapies
        10. Antisense Oligonucleotide-based Therapies
        11. Others
        12. Pharmaceutical & Biopharmaceutical Companies
        13. Diagnostic Companies
        14. Academic & Research Institutes
        15. CROs & CDMOs
      9. Rest of LATAM
        1. Instruments
        2. Reagents & Consumables
        3. Service
        4. Oligonucleotide Synthesis
        5. Gene Synthesis
        6. Research & Development
        7. Diagnostics
        8. Therapeutics
        9. RNAi Therapies
        10. Antisense Oligonucleotide-based Therapies
        11. Others
        12. Pharmaceutical & Biopharmaceutical Companies
        13. Diagnostic Companies
        14. Academic & Research Institutes
        15. CROs & CDMOs
Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.